tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LCTX Stock Latest News

Lineage Cell says first OpRegen development milestone under Roche pact achieved
The FlyLineage Cell says first OpRegen development milestone under Roche pact achieved
3d ago
CHRO
LCTX
Buy Rating Affirmed for Lineage Cell Therapeutics Amid Significant Progress in OpRegen Program and Strategic Partnership with Roche
PremiumRatings
Buy Rating Affirmed for Lineage Cell Therapeutics Amid Significant Progress in OpRegen Program and Strategic Partnership with Roche
3d ago
LCTX
Lineage Cell’s OpRegen shows evidence of progress, says H.C. Wainwright
PremiumThe Fly
Lineage Cell’s OpRegen shows evidence of progress, says H.C. Wainwright
3d ago
CHRO
LCTX
Lineage Therap Secures $5M Milestone Payment
PremiumCompany Announcements
Lineage Therap Secures $5M Milestone Payment
3d ago
8K
LCTX
Lineage Therap Sells 12 Million Shares to Janus
PremiumCompany Announcements
Lineage Therap Sells 12 Million Shares to Janus
16d ago
8K
LCTX
Positive Buy Rating for Lineage Cell Therapeutics Driven by Clinical Progress and Financial Stability
PremiumRatingsPositive Buy Rating for Lineage Cell Therapeutics Driven by Clinical Progress and Financial Stability
16d ago
LCTX
Lineage Cell Therapeutics: Progress Amid Financial Challenges
Premium
Company Announcements
Lineage Cell Therapeutics: Progress Amid Financial Challenges
20d ago
LCTX
Lineage Cell Therapeutics Reports Q3 2025 Results
Premium
Company Announcements
Lineage Cell Therapeutics Reports Q3 2025 Results
21d ago
LCTX
Lineage Cell Therapeutics reports Q3 EPS (13c), consensus (3c)
PremiumThe Fly
Lineage Cell Therapeutics reports Q3 EPS (13c), consensus (3c)
21d ago
LCTX
Is LCTX a Buy, Before Earnings?
PremiumPre-Earnings
Is LCTX a Buy, Before Earnings?
24d ago
LCTX
Lineage Cell Therapeutics Advances in Spinal Cord Injury Treatment with DOSED Study
PremiumCompany Announcements
Lineage Cell Therapeutics Advances in Spinal Cord Injury Treatment with DOSED Study
1M ago
LCTX
Lineage Cell Therapeutics: Buy Rating Affirmed on Innovative Cell Therapy Advancements and Strategic Collaborations
PremiumRatings
Lineage Cell Therapeutics: Buy Rating Affirmed on Innovative Cell Therapy Advancements and Strategic Collaborations
3M ago
LCTX
Lineage Cell Therapeutics initiates new islet cell transplant program
PremiumThe FlyLineage Cell Therapeutics initiates new islet cell transplant program
3M ago
LCTX
Lineage Cell Therapeutics’ Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Lineage Cell Therapeutics’ Earnings Call: Progress Amid Challenges
3M ago
LCTX
Buy Recommendation for Lineage Cell Therapeutics Driven by Strategic Partnerships and Financial Positioning
Premium
Ratings
Buy Recommendation for Lineage Cell Therapeutics Driven by Strategic Partnerships and Financial Positioning
3M ago
LCTX
Strategic Partnerships and Promising Trial Results Bolster Buy Rating for Lineage Cell Therapeutics
PremiumRatings
Strategic Partnerships and Promising Trial Results Bolster Buy Rating for Lineage Cell Therapeutics
3M ago
LCTX
Lineage Therap Partners with WDI for Hearing Loss Research
PremiumCompany Announcements
Lineage Therap Partners with WDI for Hearing Loss Research
3M ago
8K
LCTX
Lineage Cell Therapeutics enters research pact with William Demant Invest
PremiumThe Fly
Lineage Cell Therapeutics enters research pact with William Demant Invest
3M ago
LCTX
Promising Developments and Strong Financial Position Support Buy Rating for Lineage Cell Therapeutics
PremiumRatings
Promising Developments and Strong Financial Position Support Buy Rating for Lineage Cell Therapeutics
4M ago
LCTX
Lineage Cell Therapeutics: Strong Financials and Promising Clinical Data Drive Buy Rating
PremiumRatingsLineage Cell Therapeutics: Strong Financials and Promising Clinical Data Drive Buy Rating
4M ago
LCTX
Lineage Cell Therapeutics Reports Q2 2025 Progress and Challenges
Premium
Company Announcements
Lineage Cell Therapeutics Reports Q2 2025 Progress and Challenges
4M ago
LCTX
Lineage Cell Therapeutics reports Q2 EPS (13c), consensus (3c)
Premium
The Fly
Lineage Cell Therapeutics reports Q2 EPS (13c), consensus (3c)
4M ago
LCTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >